The Post Graduate Diploma in Drug Regulatory Affairs (PGDDRA) is a specialized one-year program designed to equip aspiring professionals with in-depth knowledge and practical skills in the regulatory domain. This program bridges the gap between academic learning and industry requirements, preparing students for a thriving career in pharmaceuticals, medical devices, biotechnology, and global regulatory bodies.
Both Residential and Distance learning modes are available, Each offering equal value, flexibility, and recognition.
The Post Graduate Diploma in Drug Regulatory Affairs (PGDDRA) offered by IILS is a comprehensive, one-year program thoughtfully structured into 4 semesters, each spanning 3 months. This program is designed to empower students with a strong academic and practical foundation in global regulatory affairs, keeping pace with evolving industry needs across pharmaceuticals, biotechnology, medical devices, and regulatory consultancy services.
Across 16 specialized modules, the curriculum covers the full scope of regulatory sciences—from the fundamentals of drug development and regulatory systems to the nuances of regulatory submissions, product registration, and compliance across international markets (USFDA, EMA, CDSCO, MHRA, TGA, WHO, etc.). The program begins with a foundational understanding of the regulatory landscape and progresses into global dossier requirements, clinical trial regulations, quality systems, GMP, GCP, regulatory intelligence, and lifecycle management.
Designed to blend theoretical instruction with practical exposure, the program incorporates real-world case studies, documentation exercises, and insights from regulatory experts to ensure students are industry-ready. By the end of the program, graduates gain not just academic knowledge but also critical regulatory thinking, technical proficiency, and confidence to navigate complex approval pathways in global markets.
At the end of each semester, candidates are required to appear for an internal assessment (semester examination). A minimum score of 50% is essential to successfully pass and advance to the next semester. This continuous evaluation approach ensures academic discipline and progressive learning throughout the course.
Candidates who have passed with a minimum of 50% Graduate or Postgraduate + Internal Assessment + P. Interview
The global Drug Regulatory Affairs market is projected to reach USD 22–25 billion by 2030, growing at a CAGR of 6–8%, driven by the expanding pharmaceutical, biotechnology, and medical device sectors. With increasing complexity in global compliance requirements, the demand for skilled regulatory professionals is at an all-time high.
High Demand, Low Supply: Despite being mission-critical, regulatory affairs remains a niche skill area with limited trained professionals, making it a strategic and rewarding career path.
Level | Experience | Average Salary (INR/Year) | Global Package (USD/Year) |
---|---|---|---|
Entry Level | 0–2 Years | ₹3.5 – ₹5.5 LPA | $40,000 – $55,000 |
Mid-Level | 3–6 Years | ₹6 – ₹10 LPA | $60,000 – $90,000 |
Senior Level | 7+ Years | ₹12 LPA & above | $100,000+ |